www.zfenglish.com - Last update 10:03
Pfizer Romania Expects To End 2017 With 16% Growth In Revenue
11.20.2017
Pfizer Romania, the subsidiary of the US pharmaceutical giant and fourth leading actor on the local pharmaceutical market, estimates to end the year with almost 750 million lei (EUR162 million) revenue, up about 16% on 2016.
To read the full story, please login. Not a member? Subscribe here.
Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed
Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)
LOGIN / Lost password?